The glial cell line-derived neurotrophic factor (GDNF) family comprise a subclass of cystine-knot superfamily ligands that interact with a multisubunit receptor complex formed by the c-Ret tyrosine kinase and a cystinerich glycosyl phosphatidylinositol-anchored binding subunit called GDNF family receptor ␣ (GFR␣). All four GDNF family ligands utilize c-Ret as a common signaling receptor, whereas specificity is conferred by differential binding to four distinct GFR␣ homologues. Binding of polypeptide growth factors to cell surface receptors is the first event in the series of protein-protein interactions leading to the distinct biological responses characteristic of a given factor. Understanding the molecular interactions underlying the affinity and selectivity of ligand-receptor complexes is of fundamental importance if we are to comprehend fully the molecular basis of signal transduction by polypeptide growth factors.
Binding of polypeptide growth factors to cell surface receptors is the first event in the series of protein-protein interactions leading to the distinct biological responses characteristic of a given factor. Understanding the molecular interactions underlying the affinity and selectivity of ligand-receptor complexes is of fundamental importance if we are to comprehend fully the molecular basis of signal transduction by polypeptide growth factors.
A large group of growth factors contain a distinctive structural motif, the "cystine knot," formed by a cluster of three disulfide bridges, with two disulfide bridges and their connecting residues forming a ring structure through which the third disulfide bridge passes (1, 2) . The protomer of cystine-knot superfamily factors is typically elongated and formed primarily by ␤ strands connected by highly flexible hairpin loops, where most of the sequence variability among paralog factors is located. Different configurations of dimer assembly lead to various shapes, elongated either along or across the 2-fold symmetry axis, which are characteristic of the different subfamilies. Two high-resolution structures of the complex of a cystine-knot factor with its corresponding receptor have been obtained recently, that of vascular endothelial growth factor with the ligand binding domain of Flt-1 (3) and the one of nerve growth factor with the ligand binding domain of TrkA (4) . In both cases, distinct immunoglobulin-like domains in the receptors are both necessary and sufficient for ligand binding. However, not all receptors of cystine-knot superfamily ligands contain immunoglobulin-like domains, suggesting the existence of novel binding domains for this class of ligands. GDNF 1 is the prototype member of a new subfamily of cystine-knot ligands with important roles in the control of neuron survival and differentiation (5) , kidney morphogenesis (6) , and sperm cell development (7) . In vertebrates, the GDNF family is known to comprise the following four distinct proteins: GDNF (8) , neurturin (NTN) (9) , persephin (PSP) (10) , and artemin (ART) (11) , also identified as enovin (12) or neublastin (13) . An unusual feature of the receptor complex for GDNF family ligands is the requirement of two receptor subunits, one specialized in ligand binding and another in transmembrane signaling. All four members of the GDNF family signal through activation of the c-Ret receptor tyrosine kinase (14 -17) . c-Ret, however, can not bind ligand on its own but requires the presence of a glycosyl phosphatidylinositol (GPI)-anchored co-receptor known as GDNF family receptor ␣ (GFR␣) (18, 19) . Interestingly, four different GFR␣ receptors have been identified (GFR␣s 1 to 4), each selective, although not totally specific, for one member of the GDNF ligand family (reviewed in Ref. 5) .
Experiments using purified proteins (20) and overexpression in cell lines (21) have demonstrated that c-Ret and GFR␣ receptors can also associate with low-affinity in the absence of ligand. In the presence of c-Ret, the ligand binding specificity of GFR␣ receptors broadens, allowing them to interact with different GDNF family ligands, as well as several mutants with defective GFR␣ binding (11, 20 -22) . In vivo, GFR␣ receptors are more widely expressed than c-Ret, suggesting additional roles for these "ectopic" sites of GFR␣ expression. Both cell-autonomous and non-cell-autonomous functions have been proposed for GFR␣ receptors expressed in the absence of c-Ret. Recent evidence obtained in c-Ret-deficient cell lines and primary sensory neurons isolated from c-Ret knock-out mice indicates the existence of alternative signaling mechanisms mediated by GFR␣ receptors acting in a cell-autonomous manner independently of c-Ret (23, 24) . GFR␣ receptors may also function in a non-cell-autonomous manner to capture and concentrate diffusible GDNF family ligands from the extracellular space and then present these factors in trans to afferent c-Retexpressing cells (25, 26) .
In the work presented here, we have explored the molecular basis of ligand recognition by GFR␣ receptors. A large collection of chimeric and truncated receptors was generated and tested in binding and c-Ret autophosphorylation assays. The results of these experiments allowed us to identify a determinant of ligand binding specificity in a central region containing four predicted ␣ helices and two short ␤ strands.
EXPERIMENTAL PROCEDURES
Reagents-The cDNAs for rat GFR␣1, rat GFR␣2, and mouse GFR␣3 subcloned in the pCDNA3 vector (Invitrogen) were obtained as described previously (21) . The cDNA for chicken GFR␣4 (27) , a gift from Alun Davies (University of Edinburgh, Edinburgh, United Kingdom), was also subcloned in pCDNA3. Monoclonal IgG against hemagglutinin was from BabCO; anti-phosphotyrosine monoclonal IgG, PY99, and goat polyclonal antibodies, C-20 and T-20, against c-Ret were from Santa Cruz Biotechnology. GDNF was prepared in Sf21 cells as described previously (28) . NTN was from Peprotech. Recombinant ART and PSP were generous gifts from Jannssen Research Foundation (Belgium). GFR␣1-Fc was from R&D Systems. Reagents for radioiodination and cross-linkings were purchased from Amersham Pharmacia Biotech, Sigma, and Pierce.
Construction of Chimeric Receptors and Deletions-An hemagglutinin (HA) epitope (YPYDVPDYA) was inserted after the putative signal peptide sequence of each GFR␣ construct by Kunkel mutagenesis (29) . Both Kunkel method and QuickChange mutagenesis (Stratagene) were used to incorporate novel restriction sites at selected conserved strings of residues PYE (BsiWI), RRR (NarI), and SGN (BspEI). Binary chimeras were prepared using these new restriction sites for segmental exchanges. Each exchange site was located in predicted loop regions in the different receptor constructs. Secondary structure predictions were done using PHD Predict (30) . Alignments were done with Clustal X. N-terminal deletions for GFR␣1 (⌬N57, ⌬N84, ⌬N113, and ⌬N144) and for GFR␣2 (⌬N126) were obtained by polymerase chain reaction using upstream primers containing the HA epitope sequence facilitating the grafting of the appropriate signal peptide using NdeI sites within the epitope and the cytomegalovirus promoter region of pCDNA3 (see Fig.  2 ). C-terminal deletions in GFR␣1 (⌬C31, ⌬C55, and ⌬C79) upstream of Gly-421 (to retain the GPI anchor) were made sequentially from the smallest to the largest truncation using QuickChange mutagenesis.
Cross-linking Assay-Ligands were radioiodinated to specific activities of about 0.5 to 2 ϫ 10 8 cpm/g by the lactoperoxidase method as described previously (28) . COS cells were transfected using DEAEdextran. 48 h after transfection, cells were rinsed once with chilled binding buffer (1 mg/ml bovine serum albumin, 1 mg/ml glucose, 0.1 mM CaCl 2 , 0.1 mM MgCl 2 in phosphate-buffered saline) and equilibrated with binding buffer containing 50 -100 ng/ml radioiodinated ligand for 4 h at 4°C. Subsequently, bis(succinimidyl) suberate (BS 3 ) cross-linker was added to a final concentration of 0.8 mM and incubated for an additional 45 min at 4°C. The reaction was quenched by adding 50 mM glycine. Cells were rinsed twice with chilled 50 mM glycine in phosphate-buffered saline and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 50 mM NaCl, 50 mM NaF, 1% IGEPAL CA-630, 0.25% sodium deoxycholate, 10% glycerol, 1 mM EDTA, 10 mM 2-glycerolphosphate, 2 mM Na 3 VO 4 ). To assess expression of the various GFR␣ constructs, an aliquot of each lysate was used for immunoblots on polyvinylidene difluoride (Hybond P) membrane processed for detection of the HA tag. The rest of the lysates were immunoprecipitated using the anti-HA antibody and run on a 10% SDS polyacrylamide gel. Immunoblot analysis was done using enhanced chemifluorescence (Amersham Pharmacia Biotech). Both immunoblot and autoradiographic exposures were detected and quantified using a Storm840 phosphor/fluorimager (Molecular Dynamics).
Phosphorylation and GFR␣-Ret Interaction Assays-Neuro2A cells were transfected with the different GFR␣ constructs by the calcium phosphate precipitation method. The day after transfection, cells were switched to serum-free medium containing 5 M all-trans retinoic acid, 0.1% bovine serum albumin, and N2 supplements and were incubated for 16 -20 h. An hour before stimulation, cells were incubated with fresh serum-free medium. Stimulations were done by adding ligands to a final concentration of 50 ng/ml for 12 min, after which cells are lysed in RIPA buffer. Aliquots were taken from each lysate for HA immunoblot analysis, whereas the rest of the lysates were used for c-Ret immunoprecipitations. c-Ret phosphorylation was assessed by immunoblotting using an anti-phosphotyrosine antibody.
To assess ligand-independent association of different GFR␣ constructs with c-Ret, co-transfections were done in COS cells using DEAEdextran. Transfected cells were lysed 48 h later in RIPA buffer containing 60 mM ␤-octylglucoside. The presence of both sodium deoxycholate and ␤-octylglucoside in the cell lysis buffer assured complete solubilization of membrane lipid rafts, which was required to establish the co-existence of both GFR␣ and c-Ret receptors in the same molecular complex, as opposed to the same subcellular compartment. Cell lysates were immunoprecipitated for c-Ret and analyzed by Western blotting with anti-HA antibodies, recognizing epitope-tagged GFR␣ constructs.
RESULTS

Specificity and Promiscuity in the Interaction of GFR␣ Receptors with GDNF Family
Ligands-No previous study had examined the binding specificity of all four GDNF family ligands to all four members of the GFR␣ receptor family in the same experiment. We used 125 I-labeled GDNF family ligands in chemical cross-linking assays to COS fibroblasts transiently expressing different GFR␣ receptors carrying an HA tag at the N terminus (Fig. 1A) . In all cases, affinity labeling of the receptor band could be prevented by addition of an excess (up to 100-fold) of the corresponding unlabeled ligand (data not shown), indicating specific binding. Western blotting of the same cell lysates with anti-HA antibodies (Fig. 1A , lower panels) was used to normalize the binding to the levels of expression of the different GFR␣ receptors for quantification. These experiments confirmed the main established interactions between GDNF family ligands and GFR␣ receptors (Fig. 1B, solid  arrows) and revealed a number of additional interactions of lower affinity between non-cognate pairs (Fig. 1B , dotted arrows). Interestingly, although GFR␣3 was only able to bind ART, this ligand was capable of interacting, to varying degrees, with all GFR␣ receptors (Fig. 1A) . Conversely, although PSP binding could only be detected to GFR␣4, this receptor was able to interact with lower affinity with all members of the GDNF ligand family (Fig. 1A) .
Domain Boundaries and Chimeric Receptors-Secondary structure predictions indicated that GFR␣ receptors contain primarily ␣ helices connected by shorter segments of undefined structure, presumably representing loops (Fig. 2) . Two predicted short ␤ strands are also conserved in the central region of all four GFR␣s (Fig. 2) . The remarkable conservation of the predicted pattern of secondary structure elements among different GFR␣ receptors suggests that these may represent true structural elements in this class of receptors. For the first set of chimeric receptors, we initially defined two internal boundaries corresponding to two highly conserved triplets in the primary sequence of GFR␣ receptors, i.e. PYE and SGN (Fig. 2) . These boundaries coincide with interhelical regions in secondary structure predictions and divide the GFR␣ molecule into Nterminal (three predicted helices), central (four predicted helices and two ␤ strands), and C-terminal (two predicted helices) domains of roughly 100, 200, and 100 residues, respectively. Similar domain boundaries have also been defined by others (5) . The percentage similarity of each of the domains in GFR␣2, -3, and -4 with respect to GFR␣1 is shown in Table I . Unique restriction sites, BsiWI and BspEI, were created by silent mutagenesis at the conserved PYE and SGN triplets, respectively, in all four GFR␣ receptors. Chimeric molecules were then constructed by exchanging homologous domains using these two restriction sites.
The N-terminal Domain Is Not a Determinant of Ligand Binding Specificity-We constructed chimeras between two relatively distant members of the GFR␣ receptor family, GFR␣1 and GFR␣3, and tested their ability to bind 125 I-labeled GDNF and ART and to activate the c-Ret receptor. These experiments indicated that the N-terminal domain is dispensable for ligand binding specificity. A receptor molecule containing the N terminus of GFR␣3 and the central and Cterminal domains of GFR␣1 (termed 3-1-1) was able to bind GDNF as efficiently as wild type GFR␣1 (Fig. 3A) . Similarly, the 1-3-3 chimera was able to bind ART, albeit somewhat less efficiently than wild type GFR␣3 (Fig. 3A) . On the other hand, exchanges involving the central and C-terminal domains disrupted ligand binding (Fig. 3A) , suggesting the requirement of FIG. 2. Conservation of predicted secondary structure elements and domain boundaries in GFR␣ receptors. The aligned amino acid sequences of rat GFR␣1, rat GFR␣2, mouse GFR␣3, and chicken GFR␣4 are shown. Sequences predicted to correspond to ␣ helices are bolded in red, and those to ␤ strands in green. Signal peptide sequences are underlined at the N termini. Conserved triplets used for silent mutagenesis (PYE, RRR, and SGN) are bolded in black, and the introduced restriction sites are indicated with open arrows. Solid curved arrows denote the boundaries of the N-and C-terminal truncations made in GFR␣1. All C-terminal truncations of GFR␣1 retain the GPI signal peptide (underlined at the C termini) and the preceding 9 residues as indicated by the last solid curved arrow on the GFR␣1 sequence. The boundaries of the ⌬C21 deletion in GFR␣1 are indicated with open curved arrows. Putative GPI cleavage sites are double underlined.
these domains for ligand interaction. The ability of the receptor chimeras to induce ligand-dependent autophosphorylation of c-Ret was examined after transient transfection into the neuroblastoma line Neuro2A, which expresses c-Ret endogenously. In agreement with the results from cross-linking experiments, only GFR␣ molecules retaining the central and C-terminal domains of GFR␣1 were able to support GDNF-dependent stimulation of c-Ret tyrosine phosphorylation (Fig. 3B) .
The results from chimeras between GFR␣1 and GFR␣3 receptors suggested that the N-terminal domain was not essential for ligand recognition and indicated the importance of the central and C-terminal segments of the GFR␣ molecule. To determine the generality of these observations for other members of the GFR␣ family, we constructed chimeras between GFR␣2 and GFR␣3 and tested their ability to bind 125 I-labeled NTN and to activate the c-Ret receptor. The only molecule capable of significant NTN binding, in addition to wild type GFR␣2, was the 3-2-2 chimera (Fig. 3C ). This result indicated that, similar to GFR␣1, the N terminus of GFR␣2 is dispensable for ligand binding specificity, and both the central and C-terminal domains are required for interaction with NTN. In agreement with the cross-linking data, the 3-2-2 chimera also supported NTN-dependent c-Ret phosphorylation (Fig. 3D) . In Neuro2A cells, however, the 2-2-3 chimera was also able to mediate ligand-dependent c-Ret phosphorylation, despite its undetectable binding to 125 I-NTN in COS cells (Fig. 3, C and  D) . These data are in accordance with previous observations indicating that c-Ret and GFR␣ receptors collaborate in the binding of suboptimal ligands and suggested that, under certain circumstances and in the presence of c-Ret, the C-terminal domain of GFR␣ receptors may also be exchanged without compromising ligand binding specificity (see below).
The Central Domain Is a Crucial Determinant of Ligand Binding Specificity-We then analyzed chimeras between more closely related receptors, i.e. GFR␣1 and -2, GFR␣1 and -4, and GFR␣2 and -4. The chimeras between GFR␣1 and GFR␣2 revealed a reciprocal pattern of binding to 125 I-GDNF and 125 I-NTN (Fig. 4A) . In all cases, the receptor chimeras showing the strongest binding to a given ligand were those retaining the central domain from the cognate receptor, i.e. X-1-X for GDNF and X-2-X for NTN. A similar pattern was observed in chimeras between GFR␣1 and -4 analyzed by affinity labeling with 125 I-GDNF (Fig. 4B ) and in chimeras between GFR␣2 and -4 analyzed with 125 I-NTN and 125 I-PSP (data not shown). Together, these data demonstrate the importance of the central domain of GFR␣ receptors for ligand recognition. In contrast to the chimeras between GFR␣1 and -3, the C-terminal domains of GFR␣1, -2, and -4 could be exchanged without loss of binding (Fig. 4, A and B) , probably because of their closer relative similarity (Table I ). This indicates that the C-terminal domain can modulate ligand binding but is not an essential determinant of specificity.
The results of c-Ret phosphorylation assays in Neuro2A cells were again in general agreement with the binding data, i.e. the chimeras with the highest activity were the ones that retained the central domain from the cognate receptor (Fig. 4, C and D) . A number of GFR␣ molecules that showed low or undetectable (Fig. 4C) . Interestingly, all chimeras between GFR␣1 and GFR␣2, as well as wild type GFR␣1, supported some degree of c-Ret activation after NTN stimulation (Fig. 4C,  lower panels) . These data are in agreement with results from previous studies demonstrating significant cross-reactivity between the GFR␣1-GDNF and GFR␣2-NTN systems in the presence of c-Ret (20, 21, 31) and support a role for c-Ret in modulating the interaction of the receptor complex with suboptimal ligands.
Binding Determinants for GDNF and NTN Reside in Discrete Subcentral Domains of GFR␣1 and GFR␣2-To further investigate structure-function relationships in the GFR␣ receptor family, we constructed chimeras involving subsegments of the central domain of GFR␣1 and GFR␣2 receptors. We took advantage of the conserved RRR triplet sequence located in the middle of the central domain, between the two predicted ␤ strands (Fig. 2) , to introduce a unique NarI site by silent mutagenesis. This new boundary subdivides the central domain into two roughly equal halves of approximately 100 residues, each predicted to contain two ␣ helices and a ␤ strand. Cross-linking studies with 125 I-GDNF indicated that the chimeras that retained binding were the ones that contained the second central subsegment from GFR␣1, i.e. corresponding to the formula X-2Ј-1Ј-X (Fig. 5A) . Conversely, the chimeras that retained binding to 125 I-NTN contained the first central subsegment from GFR␣2 (Fig. 5A) , suggesting different structural requirements for ligand binding specificity within the central domains of GFR␣1 and GFR␣2. Thus, the chimeric receptor 2-2Ј-1Ј-1, which combined both elements, had a broader specificity and was able to bind 125 I-GDNF and 125 I-NTN with comparable efficiency (Fig. 5A) . As with the previous chimeras between these two receptors, all constructs supported some level of c-Ret phosphorylation over control when introduced into Neuro2A cells (Fig. 5B) , although the molecules that bound ligand more efficiently were still the most active. This again confirms the contribution of c-Ret in ligand recognition and demonstrates that the low ligand binding efficiency of some of the chimeras was not because of structural problems in these molecules, as they were still able to support some degree of ligand-dependent c-Ret activation.
Truncated GFR␣ Receptors Lacking the N-terminal Domain Retain Ligand Binding-Although the N-terminal domain of GFR␣ receptors did not appear to play a role in ligand specificity, it was unclear whether it was at all necessary for ligand binding or it had some other function, such as contacting the c-Ret receptor. This question became all the more important in view of the proposed existence of a natural splice variant of GFR␣2 lacking the first 146 residues (termed GFR␣2c) (32) . We therefore generated truncated versions of GFR␣1 lacking the first (GFR␣1-⌬N57), the first and the second (GFR␣1-⌬N87), or all three (GFR␣1-⌬N113) predicted ␣ helices of the N-terminal domain (see Fig. 2 ). In addition, we also generated a GFR␣2 construct corresponding to the reported GFR␣2c splice variant, an analogous construct based on the GFR␣1 receptor (GFR␣1-⌬N144), and a GFR␣1 construct lacking all first four predicted ␣ helices, including predicted helix 4 in the first portion of the central domain that was essential for ligand binding (GFR␣1-⌬N161) (see Fig. 2 ). All constructs carried an HA tag at the N terminus and were analyzed in cross-linking and c-Ret phosphorylation assays as above. The GFR␣1-⌬N87 variant that lacked the first two predicted helices of the N terminus was not produced in COS cells, presumably because the deletion removed an odd number of cystines, which could have resulted in misfolding of the protein. On the other hand, all remaining N-terminally truncated variants of GFR␣1 (i.e. ⌬N57, ⌬N113, ⌬N144, and ⌬N161) were produced at normal levels (Fig. 6, A  and B) . The GFR␣1 deletion mutants ⌬N57, ⌬N113, and ⌬N144 were all able to bind GDNF, albeit with lower efficiency than the wild type receptor, particularly the ⌬N57 deletion (Fig. 6A) . The ⌬N161 deletion construct was however unable to bind GDNF (Fig. 6B ), in agreement with the importance of the central region of GFR␣ receptors for ligand binding. The
GFR␣2c splice variant (GFR␣2-⌬N146) was able to bind 125 I-NTN at a level comparable with that of wild type GFR␣2 (Fig.  6C) . Together, these data demonstrate that the N-terminal domain of GFR␣ receptors is not absolutely required for ligand binding, and, in the case of GFR␣2, an equally efficient interaction can also take place in its absence.
To investigate whether portions of the C-terminal tail of GFR␣1 may also be dispensable, we constructed a series of C-terminal truncations (see Fig. 2 ) upstream of Gly-421 and the putative GPI anchor signal sequence (last black arrow in Fig. 2 ). All three GFR␣1 C-terminal deletion constructs were produced in COS cells, and both ⌬C31 and ⌬C55 retained their ability to bind 125 I-GDNF (Fig. 6B) . A compound deletion mutant lacking 144 residues in the N terminus and 31 residues in the C terminus (GFR␣1-⌬N144⌬C31) was also able to bind GDNF (Fig. 6B) . However, the ⌬C79 deletion, which disrupts a predicted helix in the C-terminal domain of GFR␣1 (see Fig. 2 ), was unable to bind GDNF (Fig. 6B) . The region immediately downstream of this predicted helix does not appear to be necessary for GDNF binding, as indicated by the activity of the ⌬C21 deletion (Fig. 6D) . Together, these data indicate that, in the C-terminal region of GFR␣ receptors, the integrity of the predicted helices is required for ligand binding.
The N-terminal Domain of GFR␣ Receptors Is Dispensable for Ligand-dependent or -independent Interactions with c-Ret-
The question whether the N-and C-terminal domains of GFR␣ receptors play any role in the interaction with c-Ret was addressed in several ways. To investigate ligand-dependent interactions, c-Ret autophosphorylation assays were performed in Neuro2A cells carrying truncated GFR␣ receptors. In agreement with the binding data, the ⌬N57, ⌬N113, and ⌬N144 GFR␣1 truncated receptors were all able to induce GDNF-dependent stimulation of c-Ret phosphorylation (Fig. 7, A and B) , suggesting that the N-terminal domain of GFR␣1 is not crucial for the contact of the GFR␣1-GDNF complex with c-Ret. Also in agreement with their ability to cross-link 125 I-GDNF, the ⌬C31 and ⌬C55 C-terminal deletion mutants, as well as the ⌬N144⌬C31 compound mutant, also mediated ligand-dependent stimulation of c-Ret phosphorylation (Fig. 7, B and C) . Likewise, the GFR␣2c splice variant, lacking the first 146 N-terminal residues, was also able to mediate NTN-dependent c-Ret activation (Fig. 7D) . As expected, the truncated GFR␣1 receptors that did not bind GDNF (i.e. ⌬N161 and ⌬C79) were not able to stimulate c-Ret phosphorylation (Fig. 7C) .
We also determined whether the N-and C-terminal regions of GFR␣1 were required for ligand-independent interaction with the c-Ret receptor using a co-immunoprecipitation assay in transiently transfected COS cells, which do not produce detectable levels of GDNF. Care was taken to solubilize membrane lipid rafts so as to assure that co-immunoprecipitation of GFR␣1 and c-Ret reflected direct interaction and not co-existence in the same membrane compartment (see "Experimental Procedures"). Immunoprecipitation of c-Ret brought down HAtagged wild type GFR␣1 receptors only in cells that received the c-Ret expression plasmid, indicating a direct receptor-receptor interaction in the absence of ligand (data not shown). All N-and C-terminal deletions of GFR␣1 were able to interact with c-Ret in this assay, suggesting that these regions are not involved in the interaction of this receptor with c-Ret (data not shown). Intriguingly, also the GFR␣1-⌬N161 and ⌬C79 deletion mutants, which were unable to bind GDNF and to activate c-Ret, were still capable of interacting with the c-Ret receptor in a ligand-independent manner (data not shown), indicating that distinct structural determinants in GFR␣1 may be required for ligand binding and association with c-Ret, respectively.
Distinct Hydrophobic and Positively Charged Residues in the Central Domain of GFR␣1 Mediate
Binding to GDNF-To begin to identify individual amino acid residues in GFR␣1 involved in the binding of GDNF, we searched for short stretches of residues in the central domain (predicted helices 4 to 7) with chemical properties complementary to the GDNF binding surface. Previous site-directed mutagenesis studies have identified sets of hydrophobic and negatively charged residues in exposed loop regions of GDNF that are required for efficient binding to GFR␣1 (22) . Two motifs in the center of the GFR␣1 molecule, the hydrophobic triplet MLF in the first predicted ␤ strand (␤1 in Fig. 2 ) and the basic triplet RRR (NarI site in Fig.  2) , were selected for site-directed mutagenesis and functional analysis. Replacement of MLF into an alanine triplet (␣1 MLF-A 3 ) abolished binding of GFR␣1 to GDNF (Fig. 8A) . Moreover, replacement of RRR into an alanine triplet (␣1 R 3 -A 3 ) also impaired the ability of GFR␣1 to interact with GDNF (Fig. 8A) . Thus, distinct hydrophobic and positively charged residues in the central domain of GFR␣1 mediate binding to GDNF. Despite their inability to bind GDNF, however, both the MLF-A 3 and R 3 -A 3 GFR␣1 mutants retained the capacity of mediating substantial levels of c-Ret phosphorylation in the presence of GDNF (Fig. 8B) , indicating that they do not form part of the interaction site to c-Ret.
DISCUSSION
In this study, we have investigated the structural determinants required for ligand binding specificity in the family of GFR␣ receptors. This class of receptors has a unique pattern of cystine residues, predicted ␣ helices, ␤ strands, and loops spread over approximately 400 amino acid residues and lack many of the domains most commonly present in other receptors, such as leucine repeats, immunoglobulin, and fibronectinlike domains. Thus, the GFR␣ receptor family likely represents a structurally novel receptor class. Among the four members of this family, the central region of the molecule between the PYE and SGN motifs shows the highest conservation, whereas the N-terminal and, in particular, the C-terminal regions are much less conserved.
The major finding of our study is the localization of the ligand binding specificity domain of GFR␣ receptors to the central region of the molecule containing four predicted ␣ helices and two short ␤ strands (Fig. 8C) . The localization of the determinant of ligand specificity in GFR␣ receptors to the most conserved part of the molecule, as opposed to the most variable N-and C termini, was unexpected. The fact that the C-terminal domains of GFR␣1, -2, or -4 could not be substituted for that of GFR␣3 without loss of ligand binding is in agreement with the latter being the most divergent member of the GFR␣ family. Although a portion of this domain could be deleted without loss of ligand binding, the integrity of the two predicted ␣ helices present in this region could not be compromised. Together, these data suggest that some determinants in the C-terminal part of the GFR␣ molecule may also contribute to ligand binding. In contrast, the N-terminal region could be exchanged among all receptors without loss of binding. In GFR␣1 and -2, this region could be deleted without abolishing ligand interaction, indicating that it does not significantly contribute to ligand binding. Our results also indicate that the N-terminal domain of GFR␣ receptors does not participate in the recruitment and activation of the c-Ret molecule, nor in ligand-independent interactions between the two receptors. Preliminary structural analysis of GFR␣1 by cyanogen bromide digestion and Edman microsequencing indicates that the central region that was most relevant to ligand binding in GFR␣1 forms a core structural unit reinforced by disulfide bridges. 2 No disulfide bridges appear to link this core with the N-terminal region, suggesting that the latter forms a distinct structural domain, separated from the rest of the GFR␣ molecule. Interestingly, the putative mammalian homologue of the chicken GFR␣4 has recently been isolated and shown to lack the N-terminal domain altogether (33, 34) . In agreement with our findings, this molecule is still capable of binding PSP (34) . Thus, at least two GFR␣ receptor variants, the GFR␣2c splice variant and the mammalian GFR␣4 homologue, have lost the N-terminal domain without any apparent loss of function, suggesting that this region of the molecule may not be under a strong evolutionary pressure.
It is possible that the N-terminal domain of GFR␣ receptors plays other roles distinct from ligand binding. Several liganddependent signaling events have been described in cells expressing GFR␣ receptors in the absence of c-Ret (23, 24) , presumably mediated by the collaboration of GFR␣ receptors with other transmembrane proteins. Thus, it is possible that the N-terminal domain of GFR␣ receptors plays a role in the interaction with transmembrane molecules other than c-Ret. Another possibility is suggested by a recent study indicating that N-glycans, as opposed to the GPI anchor itself, mediate the apical sorting of GPI-anchored receptors in epithelial cells (35) . It is possible that the N-terminal domain of GFR␣s participates in the polarized sorting of the receptor in neurons and that alternative splicing of this domain regulates the targeting of receptor molecules to different subcellular compartments.
Two sets of residues were identified as critical for the interaction of GFR␣1 with GDNF. The MLF and RRR triplets in the central region of GFR␣1 have complementary properties to the receptor binding surface identified in GDNF, characterized by hydrophobic and negatively charged residues (22) . In GDNF, Ile-64, Leu-114, Leu-118, Tyr-120, and Ile-122 form a hydrophobic patch, whereas Asp-52, Glu-61, Glu-62, and Asp-116 form a negatively charged patch, which are both required for binding to GFR␣1, suggesting that they could be interacting with the MLF and RRR triplets, respectively, that we identified here in GFR␣1. Interestingly, the MLF and RRR sequences are highly conserved among members of the GFR␣ family (see Fig.  2 ), indicating that these residues do not represent specificity determinants but rather form part of a common epitope in GFR␣ receptors for binding to GDNF family ligands. In the neurotrophin family, the crystal structures of the ligand binding domains of Trk receptors (36) and of the TrkA-nerve growth factor complex (4), as well as extensive site-directed mutagenesis studies (37) (38) (39) (40) , bring support to the idea that specificity among related members of families of cognate ligands and receptors is provided by variable residues that modulate the affinity of a core binding interface that is common to all family members.
Interestingly, several GFR␣ chimeras, including the three point mutants made in GFR␣1 that showed no or little ligand binding, were still able to mediate ligand-dependent activation of c-Ret, indicating that suboptimal GFR␣ receptors can still contribute to the formation of a functional receptor complex in the presence of c-Ret. These data are in agreement with reciprocal observations made with several GDNF mutants and noncognate ligand-receptor pairs showing that some ligands with low or negligible affinity for individual GFR␣ receptors may still be able to activate c-Ret in a GFR␣-dependent manner (11, 20 -22) . Thus, either a residual affinity between suboptimal pairs of GDNF ligands and GFR␣s is still capable of recruiting c-Ret to stabilize the complex, or, as previously proposed, GFR␣s and c-Ret exist to some extent in a pre-formed complex that allows the interaction of suboptimal ligands or suboptimal GFR␣ molecules. In either case, our results indicate that c-Ret facilitates suboptimal interactions between GDNF family ligands and GFR␣ receptors and confirm the role of c-Ret in ligand recognition. These observations also indicate that structure-function studies of GDNF ligands and GFR␣s based only on functional responses without direct assessment of ligandreceptor binding are likely to miss the actual determinants directly involved in these interactions (see for example Ref. 41) .
Another interesting observation made in the present study concerns the two deletion constructs of GFR␣1, i.e. ⌬N161 and ⌬C79, that were still capable of forming a complex with c-Ret in the absence of ligand, despite their complete inability to bind GDNF or mediate GDNF-dependent c-Ret phosphorylation. In fact, nearly half of the GFR␣1 molecule (161 residues from the N terminus and 79 residues from the C terminus) may be deleted without affecting its ability to interact with the c-Ret receptor. This result suggests that, although ligand and c-Ret binding require the same central domain in GFR␣ receptors, distinct structural determinants within this domain participate in its interaction with GDNF and c-Ret.
In conclusion, GFR␣ receptors utilize a relatively conserved, central region of the molecule for both ligand binding and interaction with c-Ret. Other parts of the GFR␣ molecule appear to play modulatory roles in ligand binding and c-Ret activation. The N terminus in particular may have novel functions, possibly in subcellular sorting or in the interaction of GFR␣ receptors with other transmembrane molecules.
